Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

UQCRH gene encoding mitochondrial Hinge protein is interrupted by a translocation in a soft-tissue sarcoma and epigenetically inactivated in some cancer cell lines

Abstract

We previously reported the identification of a novel zinc-finger gene, designated ZSG, fused to Ewing sarcoma gene (EWS) by a submicroscopic paracentric inversion of 22q12 in a small round cell sarcoma presenting a translocation t(1;22)(p34;q12). We report here the molecular cloning and characterization of the breakpoint in 1p34, which encompasses the gene coding for mitochondrial Hinge protein ubiquinol-cytochrome C reductase hinge gene (UQCRH). All the three breakpoints, two on 22q12 and one in 1p34, interrupt different genes: EWS, ZSG and UQCRH. We determined the genomic structure of UQCRH, characterized its splicing variants and identified a transcribed processed pseudogene. The analysis of UQCRH expression in normal tissues and cancer cell lines revealed absent expression of UQCRH in two ovarian and one breast cancer cell lines and reduced expression in a further breast carcinoma cell line. CpG island methylation upstream exon 1 was detected in all the three cell lines with absent expression. Moreover, treatment with demethylating agent 5-azacytidine restored UQCRH expression in OAW42 ovarian cancer cells. These data provide preliminary evidence of the inactivation of UQCRH gene in cancer either by structural rearrangements or epigenetic mechanisms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Arvand A and Denny CT . (2001). Oncogene, 20, 5747–5754.

  • Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der MA, Taschner PE, Rubinstein WS, Myers EN, Richard III CW, Cornelisse CJ, Devilee P and Devlin B . (2000). Science, 287, 848–851.

  • Crivellone MD, Wu MA and Tzagoloff A . (1988). J. Biol. Chem., 263, 14323–14333.

  • Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, Link TA, Ramaswamy S and Jap BK . (1998). Science, 281, 64–71.

  • Jones DH and Winistorfer SC . (1997). Biotechniques, 23, 132–138.

  • Kim CH and King TE . (1983). J. Biol. Chem., 258, 13543–13551.

  • Kim CH, Yencha AJ, Bunker G, Zhang G, Chance B and King TE . (1989). Biochemistry, 28, 1439–1441.

  • Kovar H . (1998). Curr. Opin. Oncol., 10, 334–342.

  • Liu AY and Bradner RC . (1993). Cancer Res., 53, 2460–2465.

  • Mastrangelo T, Modena P, Tornielli S, Bullrich F, Testi MA, Mezzelani A, Radice P, Azzarelli A, Pilotti S, Croce CM, Pierotti MA and Sozzi G . (2000). Oncogene, 19, 3799–3804.

  • Megonigal MD, Rappaport EF, Jones DH, Williams TM, Lovett BD, Kelly KM, Lerou PH, Moulton T, Budarf ML and Felix CA . (1998). Proc. Natl. Acad. Sci. USA, 95, 6413–6418.

  • Mukai K, Miyazaki T, Wakabayashi S, Kuramitsu S and Matsubara H . (1985). J. Biochem. (Tokyo), 98, 1417–1425.

  • Ohta S, Goto K, Arai H and Kagawa Y . (1987). FEBS Lett., 226, 171–175.

  • Okazaki M, Ishibashi Y, Asoh S and Ohta S . (1998). Biochem. Biophys. Res. Commun., 243, 131–136.

  • Rustin P . (2002). Nat. Genet., 30, 352–353.

  • Santiard-Baron D, Gosset P, Nicole A, Sinet PM, Christen Y and Ceballos-Picot I . (1999). Exp. Neurol., 158, 206–213.

  • Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO and Weinstein JN . (2000). Nat. Genet., 24, 236–244.

  • Schoppink PJ, Hemrika W and Berden JA . (1989). Biochim. Biophys. Acta, 974, 192–201.

  • Schoppink PJ, Hemrika W, Reynen JM, Grivell LA and Berden JA . (1988). Eur: J. Biochem., 173, 115–122.

  • Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomaki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V and Aaltonen LA . (2002). Nat. Genet., 30, 406–410.

Download references

Acknowledgements

We thank Dr Frank Speleman for kindly providing us with the neuroblastoma cell lines, Dr Manuela Campiglio for breast cancer cell lines, and Dr Mariano Rocchi for free distribution of FISH probes (http://www.biologia.uniba.it/rmc). We are grateful to Mrs Silvia Grassi for the editing of the manuscript. This work was partially supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) and by Ministero della salute.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriella Sozzi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Modena, P., Testi, M., Facchinetti, F. et al. UQCRH gene encoding mitochondrial Hinge protein is interrupted by a translocation in a soft-tissue sarcoma and epigenetically inactivated in some cancer cell lines. Oncogene 22, 4586–4593 (2003). https://doi.org/10.1038/sj.onc.1206472

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206472

Keywords

This article is cited by

Search

Quick links